title: SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014.
abstract: This guideline is an evidence based, practical clinical approach to the management of Hypertensive Disorders of Pregnancy. Since the previous SOMANZ guideline published in 2008, there has been significant international progress towards harmonisation of definitions in relation to both the diagnosis and management of preeclampsia and gestational hypertension. This reflects increasing knowledge of the pathophysiology of these conditions, as well as their clinical manifestations. In addition, the guideline includes the management of chronic hypertension in pregnancy, an approach to screening, advice regarding prevention of hypertensive disorders of pregnancy, and discussion of recurrence risks and long term risk to maternal health. The literature reviewed included the previous SOMANZ Hypertensive Disorders of Pregnancy guideline from 2008 and its reference list, plus all other published National and International Guidelines on this subject. Medline, Cochrane Database of Systematic Reviews (CDSR), Cochrane Central Registry of Controlled Trials (CCRCT), National Institute for Health and Care Excellence (NICE) Evidence Search, and Database of Abstracts and Reviews of Effects (DARE) were searched for literature published between January 2007 and March, 2014.
authors.affiliation: Department of Medicine, Royal Hospital for Women, Sydney, New South Wales, Australia.|School of Women's and Children's Health, UNSW, Sydney, New South Wales, Australia.
authors.forename: Sandra A
authors.initials: SA
authors.lastname: Lowe
authors.affiliation: School of Women's and Children's Health, UNSW, Sydney, New South Wales, Australia.
authors.forename: Lucy
authors.initials: L
authors.lastname: Bowyer
authors.affiliation: Department of Obstetric Medicine and Internal Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia.
authors.forename: Karin
authors.initials: K
authors.lastname: Lust
authors.affiliation: Monash University & Eastern Health, Melbourne, Victoria, Australia.
authors.forename: Lawrence P
authors.initials: LP
authors.lastname: McMahon
authors.affiliation: Women's and Children's Hospital, Adelaide, South Australia, Australia.
authors.forename: Mark
authors.initials: M
authors.lastname: Morton
authors.affiliation: King's College, London, UK.
authors.forename: Robyn A
authors.initials: RA
authors.lastname: North
authors.affiliation: Department of Anaesthesia and Pain Medicine, King Edward Memorial Hospital for Women, Perth, Western Australia, Australia.
authors.forename: Michael
authors.initials: M
authors.lastname: Paech
authors.affiliation: Sunshine Hospital and University of Melbourne, Melbourne, Victoria, Australia.
authors.forename: Joanne M
authors.initials: JM
authors.lastname: Said
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001795:Blood Pressure Determination / Q000379:methods; D018450:Disease Progression; D019317:Evidence-Based Medicine; D005260:Female; D005865:Gestational Age; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000175:diagnosis / Q000188:drug therapy*; D008991:Monitoring, Physiologic / Q000379:methods; D017410:Practice Guidelines as Topic; D011225:Pre-Eclampsia / Q000175:diagnosis / Q000628:therapy*; D011247:Pregnancy; D011256:Pregnancy Outcome; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents
keywords: guideline; hypertension; management; preeclampsia; pregnancy